← Equity: Sectoral-Pharma and Healthcare
Start this SIP →
HDFC Mutual Fund · Equity: Sectoral-Pharma and Healthcare
HDFC Pharma and Healthcare Fund - Growth Option
To provide long-term capital appreciation by investing predominantly in equity and equity related securities of Pharma and healthcare companies. There is no assurance that the investment objective of the Scheme will be achieved.
EquityBenchmark · BSE Healthcare IndexTER · 2.88%Inception · 04-10-2023
NAV
₹19.28
+1.57% · as of 14-05-2026
Since inception
28.75%
CAGR
Benchmark (inception)
14.86%
CAGR
Fund size
₹22 Cr
AUM
Expense ratio
2.88%
30-04-2026
Performance
Returns vs benchmark & category
Since inception: +28.75% CAGR vs benchmark +14.86%.
Portfolio
Where the money is invested
Top holdings
SUN PHARMACEUTICAL INDUSTRIES LTD. EQ NEW F.V. RE.1/-10.20%
DIVIS LABORATORIES LIMITED EQ NEW RS. 2/-8.20%
GLENMARK PHARMACEUTICALS LIMITED EQ NEW FV RE.1/-6.78%
LUPIN LIMITED EQ NEW F.V. RS.2/-6.65%
ALKEM LABORATORIES LIMITED EQ5.99%
MAX HEALTHCARE INSTITUTE LIMITED EQ5.96%
ASTER DM HEALTHCARE LIMITED EQ5.70%
IPCA LABORATORIES LIMITED EQ NEW FV RE .1/-5.16%
Ami Organics Limited4.39%
ANTHEM BIOSCIENCES PRIVATE LIMITED EQ NEW FV Rs. 2/-4.29%
Sector allocation
Healthcare98.52%
Riskometer
LowVery High
Very High
What if you'd SIP'd here?
@ 28.8% p.a.₹10,000
10 years
Projected value
₹68,95,791
Invested: ₹12,00,000
Gained: ₹56,95,791
Illustration based on fund's since-inception return. Past performance is not indicative of future returns.
Risk Analysis
How this fund manages risk
Fund manager
N
Nikhil Mathur
Manager since fund inception data not available
ISIN & identifiers
AMFI code
152084
ISIN (Growth)
INF179KC1HL7
ISIN (Div Re-inv)
—
Status
Open Ended Schemes
Peers
Other Equity: Sectoral-Pharma and Healthcare funds
WhiteOak Capital Pharma and Heathcare Fund Reg Plan Gr
₹15.00
1Y
+16.9%
3Y
+0.0%
5Y
+0.0%
Mirae Asset Healthcare Reg Gr
₹42.26
1Y
+15.4%
3Y
+26.3%
5Y
+15.1%
Kotak Healthcare Reg Gr
₹14.93
1Y
+14.8%
3Y
+0.0%
5Y
+0.0%
UTI Healthcare Reg Gr
₹307.13
1Y
+13.2%
3Y
+27.0%
5Y
+14.4%
ABSL Pharma and Healthcare Reg Gr
₹33.49
1Y
+13.2%
3Y
+24.8%
5Y
+13.2%
Want a personalised recommendation?
Our team will tell you whether this fund fits your goals, allocation and risk profile — and suggest peers if it doesn't.